Recipharm AB ceases manufacturing of sterile products in Ashton-under-Lyne, UK
During October 2010 it was announced that following a strategic review, Recipharm Ltd would cease manufacturing of sterile products at the facility in Ashton-under-Lyne in the UK during 2012.
Regrettably, we have had to take the decision to cease sterile manufacturing with immediate effect and therefore no more sterile products will be produced at the Ashton facility.
All other manufacturing and packaging operations will continue as normal (solid dose, creams and dry powder inhalers).
Whilst we had originally planned to keep the sterile manufacturing unit operating into 2012, there have been repeated failures of critical equipment. Despite every effort from our Technical, Production and Quality teams, we have reached a point where the correct GMP decision is to cease sterile operations. The decision has been reached with the full knowledge of the MHRA Inspectorate and the Dept. of Health.
We very much regret the necessity for immediate closure but this decision has been taken with the requirements of GMP and patient safety in mind.